How Hospital Supply Chains Manage Vascular Access Inventory

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Ask any charge nurse what happens when a central line cart is missing an introducer kit and you’ll get the same answer every time: the procedure stops. A tech gets sent running to a neighboring unit or someone on the supply chain team is suddenly placing an emergency order at 2 a.m.  “Almost in stock” […]

The post How Hospital Supply Chains Manage Vascular Access Inventory appeared first on Medical News Bulletin.

What to Look For in a Birth Injury Attorney?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

If your child was hurt during delivery because of a medical mistake, you’ve probably already Googled some version of this question. And honestly, “best” is tricky. It depends on where you live, what happened, and how severe the injury is. A family in Dallas dealing with a cerebral palsy diagnosis needs a very different kind […]

The post What to Look For in a Birth Injury Attorney? appeared first on Medical News Bulletin.

Why Does Food Get Stuck Between Your Teeth and What Could It Mean?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Getting food stuck between your teeth now and then is nothing to stress about. A bit of brushing and flossing usually clears it right up. But if it keeps happening in that one same spot, that is your teeth trying to tell you something. It could be a cavity forming or a filling that has […]

The post Why Does Food Get Stuck Between Your Teeth and What Could It Mean? appeared first on Medical News Bulletin.

Cancer Death Rates, Good News and Bad News for the under 50s

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Public health researchers report that the number of Canadians under 50 dying from nine of the top 10 most deadly cancers has been trending down since the turn of the century. In a study published in August 2026 in JAMA Network Open, epidemiologists looked back at cancer deaths over 24 years to see how Canucks […]

The post Cancer Death Rates, Good News and Bad News for the under 50s appeared first on Medical News Bulletin.

FDA extends approval of Tivicay to treat newborns with HIV

The FDA has extended its approval of dolutegravir tablets for oral suspension to treat newborns with HIV.
Dolutegravir tablets (Tivicay, ViiV Healthcare) and dolutegravir tablets for oral suspension (Tivicay PD, ViiV) were previously approved for adults and infants aged at least 4 weeks and weighing 3 kg or more.
Now, Tivicay PD will also be available to treat HIV in infants weighing at least 2 kg from birth up to age 4 weeks, the FDA announced Tuesday.
According to the agency, the approval was supported by phase 1 data showing that drug levels of Tivicay PD among 48 newborns enrolled in the

ICL implantation may improve dynamic visual acuity

Patients with myopia had better dynamic visual acuity after receiving an ICL, according to a study published in Journal of Refractive Surgery.
Tianze Huang, MD, of Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, and colleagues wrote that because dynamic visual acuity (DVA) indicates how well someone can identify the details of a moving object, it can be an important tool for clinicians to assess a patient’s full visual function.
“Current evaluation of visual function mainly focuses on SVA indicators, including corrected (CDVA) and uncorrected (UDVA)

FDA authorizes Avulux lenses for migraine light sensitivity

The FDA granted de novo marketing authorization for Avulux lenses, which are intended to address light sensitivity associated with migraine.
The lenses are designed to decrease light sensitivity in people aged 12 years or older with episodic migraine. They block light at wavelengths of 480 nm and 590 nm, the high blue range and the red/amber range, respectively, according to the company.
The lenses should be used “alongside a patient’s existing care, not in place of it,” including any medications, Charles Posternack, MD, president, CEO and cofounder of Avulux, told Healio.
The FDA uses de novo

Ziihera-Tevimbra combo grabs FDA nod in gastroesophageal cancers

The FDA approved two zanidatamab-hrii-based regimens as first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.
Zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) received approval in combination with fluoropyrimidine- and platinum-containing chemotherapy, and in combination with both fluoropyrimidine- and platinum-containing chemotherapy and tislelizumab-jsgr (Tevimbra, BeOne Medicines USA).
The FDA based its decision on the randomized, three-arm HERIZON-GEA-01 trial, which showed a 37% improvement in PFS with

High fluoride levels tied to lower cognition scores in children

Prenatal fluoride exposure in public drinking water at levels below WHO and EPA maximums is nonlinearly associated with lower fluid cognition scores in children, according to data published in the American Journal of Epidemiology.
While past research has found an association between fluoride exposures greater than 1.5 mg/L and lower child IQ, there was insufficient evidence of associations when dealing with lower concentrations of fluoride, said Katrina R. Simon, PhD, postdoctoral research fellow with the Columbia University Mailman School of Public Health.
“Our study fills an important gap by

Hooked on Dermatology with Michael H. Gold, MD

When I was 16 years old, my acne was so bad that I had seen numerous dermatologists. I had the worst acne I have seen in practice, minus maybe five or 10 people. I tried every kind of medicine available.
One doctor wanted to give me intralesional steroids, and, at 16, I was very needle phobic. I ran out of his office, my mother told me, because I was so scared of having somebody put a needle in my face. Ironically, I do that every day now.
At that time, my father worked at a pharmaceutical company and was part of the University of Pennsylvania. He knew the late Albert Kligman, MD, the